Trial Details
NOT_YET_RECRUITINGBasic Information
| Clinical ID | c586 |
|---|---|
| Identifier | NCT05659953 |
| Trial Title | LMT503 First-in-human SAD, MAD, and FE Study |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Inflammatory Bowel Disease|Colitis, Ulcerative|Crohn Disease |
| Interventions | DRUG: LMT503|DRUG: Placebo |
Participant Information
| Sponsor | Lmito Therapeutics Inc. |
|---|---|
| City | Groningen |
| Country/Region | Netherlands |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2025-04-01 |
|---|---|
| Primary Completion Date | 2025-10-01 |
| Completion Date | 2026-03-01 |